Extended University

Biotechnology Webinar Speaker Series, Spring 2010

This course gives MS Biotechnology and Dual Degree MS/MBA students a first exposure to

selected speakers from biotechnology academia and industry. All speakers will present their

functional area expertise in order to provide a basic understanding of all relevant activities and

critical issues emerging in the entire biotechnology value chain spanning from early drug

discovery research to development to commercialization. All speakers will provide their

information to students in a way demonstrating various sciences, scientific disciplines and the

scientific method are applied in various disciplines in the biotechnology industrial setting. Via the

presentation, Q/A and exexutive summary report formate, students will gain the basic understanding

of scientific content, language and key critical issues of biotechnology innovation,

research, development and commercialization, relevant in academic and industry R&D. The

students will gain insights into current and future relevant areas of biotechnology research,

development and commercialization. Students are asked to independently prepare all

presentation topics & generate key questions beforehand based on overview literature provided.

The Executive Summary Report approach aims to ensure students ability to critically think about

the biotechnology topic area, prepare questions, and summarize presentation contents, key

issues and and respective Q/A in a structured, organized and concise manner. Students will be

mandated to provide this executive summary formate after every Biotechnology seminar within a

pre-defined timeframe. The students will gain the basic understanding that all research,

development and commercialization activities are not only highly complex, but more importantly

are not conducted independently and are highly integrated, interdependent and interconnected in

order to deliver a commercializable biotechnology product.

Schedule

Thursday, April 8, 2010 (6:00-7:30pm PST)

THOMAS J SCHULZE, PhD, PMP®

President, TAON™ Biopharma Consulting Inc.,

Title: "Pharmaceutical & Biotechnology Research and Drug Discovery: An Overview".

Thursday, April 15, 2010 (6:00-7:30pm PST)

JESPER HAANING, PhD

Director, Head Hematology Research Bayer Schering Pharmaceuticals

Working Title: "Protein Research and Drug Discovery in Biotechnology."

Thursday, April 22, 2010 (6:00-7:30pm PST)

UMA LAKSHMIPATHY, PhD

Research Scientist, Life Technologies Inc.

Working Title: "Stem Cell Research in Industrial Biotechnology."

Thursday, April 29, 2010 (6:00-7:30pm PST)

JOHN LAUDEMANN, MS

Associate Scientist Protein Sciences, Amgen Inc.

Working Title: "Therapeutic Proteins in Biotechnology R&D."

Thursday, May 6, 2010 (6:00-7:30pm PST)

CHRIS ROBERTSON, PharmD

Project Team Leader KYTHERA Biopharmaceuticals

Title: "KYTHERA Biopharmaceuticals – An Innovative Approach to Bringing Innovation to

Aesthetic Medicine".

Thursday, May 13, 2010 (6:00-7:30pm PST)

ED MOORE, PhD,

Senior Director Research & Development, Baxter Medication Delivery

Working Title: "Protein Analytics & Analytical Development in Biotechnology R&D".

Thursday, May 20, 2010 (6:00-7:30pm PST)

ANASTASSIOS D RETZIOS, PhD,

CEO, Bay Area Clinical R&D Services

Working Title: "Clinical Drug Development in Biopharmaceutical R&D."

Thursday, May 27, 2010 (6:00-7:30pm PST)

MARIANNE MANCINI, MS, MBA

Senior Director Clinical Program Management Arena Pharmaceuticals

Title: "Clinical Program Management"

Thursday, June 3, 2010 (6:00-7:30pm PST)

PHIL BECCUE,

Director, Strategic Portfolio Management & Decision Analysis Baxter Bioscience

Title: "From Molecule To Market: Project Portfolio Management & Decision Analysis in

Biopharmaceutical R&D".

Thursday, June 10, 2010 (6:00-7:30pm PST)

MEHRSHID ALAI-SAFAR, PhD, PMP®,

Senior Director Global Regulatory Affairs Baxter Bioscience

Title: "Biopharmaceutical Chemistry, Manufacturing, Control (CMC): Collaboration

Between Different Functions".

Thursday, June 17, 2010 (6:00-7:30pm PST)

Thomas H. BLISS Jr., MBA

CEO, Therakyn Inc.

Working Title: "Business Development & Licensing in the Biopharmaceutical Industry"

Thursday, June 24, 2010 (6:00-7:30pm PST)

Dan MYTYCH, PhD

Scientist Immunology, Amgen Inc.

Working Title: "Human Therapeutic Antibodies